PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial
Clinical trial NCT05520814 · UNKNOWN
Trial details
- NCT number
- NCT05520814
- Sponsor
- Sichuan Cancer Hospital and Research Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2023-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.